Breaking News Instant updates and real-time market news.

AET

Aetna

$125.34

-4.15 (-3.20%)

13:59
02/17/17
02/17
13:59
02/17/17
13:59

Aetna trading halted, news pending

AET Aetna
$125.34

-4.15 (-3.20%)

02/07/17
02/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Target (TGT) and Dollar General (DG) were initiated with an Outperform at Bernstein, while Lowe's (LOW) was initiated with an Underperform. The firm also initiated Costco (COST), Home Depot (HD), and Wal-Mart (WMT) with a Market Perform. 2. Aetna (AET) and UnitedHealth (UNH) were assumed with an Overweight at Cantor. 3. Philips (PHG) initiated with a Hold at Berenberg. 4. Costamare (CMRE) initiated with a Neutral at Citi. 5. BioMarin (BMRN) initiated with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/09/17
LEER
02/09/17
NO CHANGE
Target $170
LEER
Outperform
WellCare price target raised to $170 from $160 at Leerink
Leerink analyst Ana Gupte raised her price target for WellCare (WCG) to $170 from $160 following the company's "strong" EPS beat in Q4. The analyst believes WellCare is largely insulated from the downside of the Affordable Care Act "Repeal and Replace" given it had no exposure to Public Exchanges, while its exposure to Medicaid expansion is limited. Gupte sees a takeout as likely, with Aetna (AET) as the most likely buyer followed by Cigna (CI) or Anthem (ANTM). She reiterates an Outperform rating on WellCare's shares.
02/15/17
PIPR
02/15/17
NO CHANGE
Target $231
PIPR
Overweight
Deal termination positive for Humana, says Piper Jaffray
Piper Jaffray analyst Sarah James believes Humana (HUM) is in a stronger position today than when Aetna (AET) announced its merger offer. The analyst views the deal termination as a positive since she feels Humana is more valuable than the merger price. James keeps an Overweight rating on the shares with a $231 price target.
02/15/17
FBCO
02/15/17
NO CHANGE
Target $220
FBCO
Outperform
Humana price target raised to $220 from $208 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for Humana (HUM) to $220 from $208 following the termination of the company's proposed merger with Aetna (AET). The analyst believes Humana offers investors some "new sweets" post "Valentine's Day Break-up," including 2017 EPS guidance above the Street view, an increase in its dividend, a new share buyback, and a full exit from its beleaguered public exchange business in 2018. The analyst reiterates an Outperform rating on Humana's shares.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.